Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway
|更新时间:2026-01-23
|
Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway
“The latest research has found that the combination of Shenmai injection and cisplatin has a synergistic anti-tumor effect on non-small cell lung cancer, which may be related to activating the endoplasmic reticulum stress PERK/eIF2 α/ATF4/CHOP signaling pathway and inducing tumor cell apoptosis.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 32, Issue 4, Pages: 70-78(2026)
GUO Shengnan,CAO Hao,WANG Dan,et al.Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(04):70-78.
GUO Shengnan,CAO Hao,WANG Dan,et al.Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(04):70-78. DOI: 10.13422/j.cnki.syfjx.20250825.
Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway